Laura A. Francis
SI-BONE, Inc.
Laura A. Francis has served as Chief Executive Officer and a Director on SI-Bones Board since April 2021. In previous positions as chiy public in October 2018 and building the operations of the business. Prior to joining SI-BONE, Laura held executive and leadership roles with public and private life science companies, including Auxogyn, now part of Progyny, Promega Corporation, and Bruker Corporation. Earlier in her career, she was an engagement manager with McKinsey & Company and audit manager with Coopers & Lybrand, now PricewaterhouseCoopers. She has been a Director for Shockwave Medical since January 2019, where she serves as Audit Committee chair and Compensation Committee member. Laura received a B.B.A. from the University of Wisconsin and an M.B.A. from Stanford University.